Utility of Cinacalcet in Familial Hypocalciuric Hypercalcemia.
作者信息
Sethi Bipin Kumar, Nagesh V Sri, Kelwade Jayant, Parekh Harsh, Dukle Vaibhav
机构信息
Department of Endocrinology, CARE Hospital, Banjara Hills, Hyderabad, Telangana, India.
出版信息
Indian J Endocrinol Metab. 2017 Mar-Apr;21(2):362-363. doi: 10.4103/2230-8210.202034.
Abstract
摘要
相似文献
1
Utility of Cinacalcet in Familial Hypocalciuric Hypercalcemia.西那卡塞在家族性低钙血症性高钙血症中的应用
Indian J Endocrinol Metab. 2017 Mar-Apr;21(2):362-363. doi: 10.4103/2230-8210.202034.
2
Parathyroid glands in familial benign hypercalcemia (familial hypocalciuric hypercalcemia).家族性良性高钙血症（家族性低钙尿性高钙血症）中的甲状旁腺
Am J Med. 1984 Jun;76(6):1021-6. doi: 10.1016/0002-9343(84)90852-0.
3
The parathyroid glands in familial hypocalciuric hypercalcemia.家族性低钙血症性高钙血症中的甲状旁腺
Hum Pathol. 1981 Mar;12(3):229-37. doi: 10.1016/s0046-8177(81)80123-2.
4
Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype.家族性低钙血症性高钙血症和新生儿重症甲状旁腺功能亢进症。突变基因剂量对表型的影响。
J Clin Invest. 1994 Mar;93(3):1108-12. doi: 10.1172/JCI117062.
5
Familial hypocalciuric hypercalcemia. Mild expression of the gene in heterozygotes and severe expression in homozygotes.家族性低钙尿性高钙血症。该基因在杂合子中轻度表达，在纯合子中重度表达。
Am J Med. 1985 Jan;78(1):15-22. doi: 10.1016/0002-9343(85)90455-3.
6
Cinacalcet sustainedly prevents pancreatitis in a child with a compound heterozygous SPINK1/AP2S1 mutation.西那卡塞持续预防了一名复合杂合 SPINK1/AP2S1 突变患儿的胰腺炎。
Pancreatology. 2019 Sep;19(6):801-804. doi: 10.1016/j.pan.2019.07.045. Epub 2019 Jul 30.
7
Familial hypocalciuric hypercalcemia and related disorders.家族性低钙血症性高钙血症及相关疾病。
Best Pract Res Clin Endocrinol Metab. 2018 Oct;32(5):609-619. doi: 10.1016/j.beem.2018.05.004. Epub 2018 May 26.
8
Correction of hypercalcaemia by cinacalcet in familial hypocalciuric hypercalcaemia.西那卡塞对家族性低钙血症性高钙血症患者高钙血症的纠正作用
Clin Endocrinol (Oxf). 2008 Feb;68(2):324-5. doi: 10.1111/j.1365-2265.2007.03027.x. Epub 2007 Sep 4.
9
Maximal urine-concentrating ability: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.最大尿浓缩能力：家族性低钙血症性高钙血症与典型原发性甲状旁腺功能亢进症的比较
J Clin Endocrinol Metab. 1981 Apr;52(4):736-40. doi: 10.1210/jcem-52-4-736.
10
An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds.三个家族中新生儿严重原发性甲状旁腺功能亢进与家族性低钙血症性高钙血症之间的关联。
N Engl J Med. 1982 Feb 4;306(5):257-64. doi: 10.1056/NEJM198202043060502.
引用本文的文献
1
Genotype-Phenotype Correlations in Asian Indian Children and Adolescents with Primary Hyperparathyroidism.原发性甲状旁腺功能亢进症的亚洲印度儿童和青少年的基因型-表型相关性。
Calcif Tissue Int. 2022 Sep;111(3):229-241. doi: 10.1007/s00223-022-00985-x. Epub 2022 May 14.
2
Disorders of the Calcium Sensing Signaling Pathway: From Familial Hypocalciuric Hypercalcemia (FHH) to Life Threatening Conditions in Infancy.钙感知信号通路紊乱：从家族性低钙血症高钙血症（FHH）到危及婴儿生命的病症
J Clin Med. 2022 May 5;11(9):2595. doi: 10.3390/jcm11092595.
3
International Union of Basic and Clinical Pharmacology. CVIII. Calcium-Sensing Receptor Nomenclature, Pharmacology, and Function.国际基础和临床药理学联合会。CVIII. 钙敏感受体命名、药理学和功能。
Pharmacol Rev. 2020 Jul;72(3):558-604. doi: 10.1124/pr.119.018531.
4
Use of calcimimetics in children with normal kidney function.在肾功能正常的儿童中使用钙敏感受体激动剂。
Pediatr Nephrol. 2019 Mar;34(3):413-422. doi: 10.1007/s00467-018-3935-1. Epub 2018 Mar 19.
5
Calcimimetic and calcilytic therapies for inherited disorders of the calcium-sensing receptor signalling pathway.钙敏感受体信号通路遗传性疾病的钙敏感受体激动剂和拮抗剂治疗。
Br J Pharmacol. 2018 Nov;175(21):4083-4094. doi: 10.1111/bph.14086. Epub 2017 Dec 11.
本文引用的文献
1
Cinacalcet for Symptomatic Hypercalcemia Caused by AP2S1 Mutations.西那卡塞治疗由AP2S1突变引起的症状性高钙血症
N Engl J Med. 2016 Apr 7;374(14):1396-1398. doi: 10.1056/NEJMc1511646.
2
Clinical and biochemical outcomes of cinacalcet treatment of familial hypocalciuric hypercalcemia: a case series.西那卡塞治疗家族性低钙血症性高钙血症的临床和生化结果：病例系列
J Med Case Rep. 2011 Dec 5;5:564. doi: 10.1186/1752-1947-5-564.
3
Neonatal hyperparathyroidism with a heterozygous calcium-sensing receptor (CASR) R185Q mutation: clinical benefit from cinacalcet.杂合性钙敏感受体（CASR）R185Q 突变导致的新生儿甲状旁腺功能亢进症：西那卡塞的临床获益。
J Clin Endocrinol Metab. 2011 Apr;96(4):E707-12. doi: 10.1210/jc.2010-1306. Epub 2011 Feb 2.
4
Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity.盐酸西那卡塞可降低各种严重程度原发性甲状旁腺功能亢进症的高钙血症。
J Clin Endocrinol Metab. 2011 Jan;96(1):E9-18. doi: 10.1210/jc.2010-1221. Epub 2010 Oct 13.
5
Beneficial effect of cinacalcet in a child with familial hypocalciuric hypercalcemia.西那卡塞治疗家族性低钙血症性高钙血症患儿的疗效。
Pediatr Nephrol. 2010 Sep;25(9):1747-50. doi: 10.1007/s00467-010-1547-5. Epub 2010 May 22.
6
Correction of hypercalcaemia by cinacalcet in familial hypocalciuric hypercalcaemia.西那卡塞对家族性低钙血症性高钙血症患者高钙血症的纠正作用
Clin Endocrinol (Oxf). 2008 Feb;68(2):324-5. doi: 10.1111/j.1365-2265.2007.03027.x. Epub 2007 Sep 4.
7
Normalization of serum calcium by cinacalcet in a patient with hypercalcaemia due to a de novo inactivating mutation of the calcium-sensing receptor.西那卡塞使一名因钙敏感受体新发失活突变导致高钙血症患者的血清钙恢复正常。
J Intern Med. 2006 Aug;260(2):177-82. doi: 10.1111/j.1365-2796.2006.01684.x.
8
Familial hypocalciuric hypercalcemia and other disorders with resistance to extracellular calcium.家族性低钙尿性高钙血症及其他对细胞外钙有抵抗的疾病。
Endocrinol Metab Clin North Am. 2000 Sep;29(3):503-22. doi: 10.1016/s0889-8529(05)70148-1.
9
Inter-relations between the calcium set-points of Parfitt and Brown in primary hyperparathyroidism: a sequential citrate and calcium clamp study.原发性甲状旁腺功能亢进症中帕菲特和布朗钙设定点之间的相互关系：一项连续柠檬酸盐和钙钳夹研究。
Eur J Clin Invest. 1994 Aug;24(8):553-8. doi: 10.1111/j.1365-2362.1994.tb01106.x.
Zotero 插件